Bergers, Gabriele

Tumorigenesis and the angiogenic switch

Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer

Angiogenesis and VEGF in CancerCancer Cells and Metastasis

Cited by 3,559

Modes of resistance to anti-angiogenic therapy

Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer

Angiogenesis and VEGF in CancerCancer Cells and Metastasis

Cited by 2,953

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology

Angiogenesis and VEGF in CancerProtease and Inhibitor Mechanisms

Cited by 2,797

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 1,621

The role of pericytes in blood-vessel formation and maintenance

Bergers, G., & Song, S. (2005) · Neuro-Oncology

Angiogenesis and VEGF in CancerBarrier Structure and Function Studies

Cited by 1,584

Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice

Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science

Angiogenesis and VEGF in CancerMathematical Biology Tumor Growth

Cited by 988

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., Vandenberg, S. R., Ginzinger, D. G., James, C. D., Costello, J. F., et al. (2008) · BMC Medicine

MicroRNA in disease regulationGlioma Diagnosis and Treatment

Cited by 957

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development

Angiogenesis and VEGF in CancerMast cells and histamine

Cited by 946

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

Allen, E., Jabouille, A., Rivera, L. B., Lodewijckx, I., Missiaen, R., Steri, V., Feyen, K., Tawney, J., Hanahan, D., Michael, I. P., et al. (2017) · Science Translational Medicine

Cancer Immunotherapy and BiomarkersAngiogenesis and VEGF in Cancer

Cited by 820

Glioblastoma: defining tumor niches

Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer

Glioma Diagnosis and TreatmentCancer, Hypoxia, and Metabolism

Cited by 522

The hypoxic response of tumors is dependent on their microenvironment

Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.-P., Johnson, R. S., & Bergers, G. (2003) · Cancer Cell

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 408